Reliefband Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 10

  • Latest Deal Type
  • M&A

  • (Announced)
  • Latest Deal Amount
  • $33.5M

  • Investors
  • 4

Reliefband General Information


Developer of a digital therapeutic device designed to treat nausea, retching, and vomiting. The company's device offers a clinically proven, FDA-cleared wearable technology for the treatment of anxiety, migraine associated with a hangover, morning sickness, and VR gaming chemotherapy and as an adjunct to post-op nausea, and offers pre-programmed pulses with specific waveform, frequency, and intensity of stimulation for the median nerve on the underside of the wrist, enabling patients to reclaim life from uncomfortable moments of nausea and provides long-lasting relief without any side effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 220 Gibraltar Road
  • Suite 270
  • Horsham, PA 19044
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reliefband Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 17-Oct-2022 $33.5M 00.00 000.00 Announced Generating Revenue
3. Later Stage VC 30-Jun-2020 00.000 00.00 Completed Generating Revenue
2. Early Stage VC 30-Nov-2016 Cancelled Startup
1. Early Stage VC (Series A) 15-Dec-2015 $5M $5M Completed Startup
To view Reliefband’s complete valuation and funding history, request access »

Reliefband Patents

Reliefband Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210205169-A1 Electro-acupuncture device for controlling nausea Pending 06-Jan-2020 0000000000
US-20190209838-A1 Electrodes for use in electrical stimulation devices and associated methods Inactive 05-Jan-2018 00000000000
US-20200222279-A1 Wearable device for delivering electrical stimulation to the p6 acupuncture point Inactive 05-Jan-2018 0000000000
US-20190209830-A1 Treatment of vertigo using electrical stimulation Inactive 05-Jan-2018 0000000000
US-20190209829-A1 Treatment of alcohol hangover using electrical stimulation Inactive 05-Jan-2018 A61N1/0456 0
To view Reliefband’s complete patent history, request access »

Reliefband Executive Team (4)

Name Title Board Seat Contact Info
Richard Ransom Chief Executive Officer & President
Susan Feiner Chief Financial Officer
Gene Godick Executive Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Reliefband Board Members (7)

Name Representing Role Since
Bruce Carbonari Self Chairman of the Board 000 0000
Cameron Durrant MD Self Board Member 000 0000
David Jonas JVC Investment Partners Board Member 000 0000
Jeffrey Nicholas ESQ Reliefband Board Member 000 0000
Wilbur Gantz III PathoCapital Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Reliefband Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reliefband Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anthony Gellert Angel (individual) Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group Minority 000 0000 000000 0
JVC Investment Partners Venture Capital Minority 000 0000 000000 0
PathoCapital Venture Capital Minority 000 0000 000000 0
To view Reliefband’s complete investors history, request access »